Speaker illustration

Doctor Florian Kahles

RWTH University Hospital Aachen, Internal Medicine I, Cardiology, Pulmonology & Vascular Medicine, Aachen (Germany)

The gut hormone GIP predicts CV prognosis in patients with acute myocardial infarction

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters

Thumbnail

The gut hormone GLP-2 predicts cardiovascular risk in patients with acute myocardial infarction

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Coronary Syndromes ePosters

Thumbnail

Activation of the GIP system attenuates pathological vascular remodeling by decreasing infiltration and proinflammatory activation of monocytes in ApoE-/- mice

Event: ESC CONGRESS 2017

Topic: Inflammation, growth factors and signal transduction-vascular

Session: Vascular inflammation

Thumbnail

The PDE-4 inhibitor roflumilast reduces body weight and improves glucose metabolism by increasing energy expenditure and mitochondrial respiration

Event: ESC CONGRESS 2016

Topic: Metabolism and metabolic syndromes

Session: Integrative physiology and pathology

Thumbnail

This platform is supported by

logo Novo Nordisk